Healthcare & Pharmaceuticals
Supporting enterprises across Asia’s healthcare ecosystem
Healthcare & Pharmaceuticals
Supporting enterprises across Asia’s healthcare ecosystem
With an extensive Asian network and insights on the region’s healthcare sector, DBS offers critical connections and dedicated coverage across all segments of the industry. Present in 51 cities and across 18 markets, we are well-represented in Asia to support our clients in the region.
Our sectors: healthcare service providers, healthcare asset owners (REITs), medical devices, pharmaceuticals, Traditional Chinese Medicine (TCM) and healthcare distribution.
Our capabilities: Global Transaction Services, syndicated debt, Debt Capital Markets and Equity Capital Markets.
-
Financing
Offering a range of solutions to support your loan syndication and working capital needs
-
Advisory
Leverage our expertise in strategic advisory, deal making, project finance and acquisition financing
-
Global Financial Markets
Access innovative hedging solutions to mitigate foreign exchange and interest rate risks
-
Transaction Services
Cash management, trade finance, supply chain finance and custody services all in one place
-
Capital Markets
Offering global debt and equity financing through our full-service solutions
The Asset
Treasury, Trade, SSC & Risk Management Awards
Best Payments and Collections Solution for Mount Alvernia Hospital, 2020
HealthInvestor Asia Awards
- Corporate Finance Team of the Year, 2019
- Grand Prix, Deal Team of the Year, 2019
HealthInvestor Asia Awards
Finance House of the Year, 2018
The Asset
Treasury, Trade, SSC & Risk Management Awards
Best Payments and Collections Solution for Mount Alvernia Hospital, 2020
HealthInvestor Asia Awards
- Corporate Finance Team of the Year, 2019
- Grand Prix, Deal Team of the Year, 2019
HealthInvestor Asia Awards
Finance House of the Year, 2018
Automating the reconciliation process
The ENCORE solution has helped the hospital reduce time spent on checking the claims status for every submission.
-
Whitepaper: Reimagining Healthcare
Lessons from the financial sector in digital transformation -
Positive Outlook in Vietnam’s Healthcare Industry
Capture business opportunities at lower costs in this untapped market.
Healthcare & Pharmaceuticals Industry Perspectives
Supporting enterprises across Asia’s healthcare ecosystem.
Future of the healthcare industry
The changes in the healthcare industry.
Key takeaways for the Indian pharma sector
The need to realign strategy, drug pipelines and market segments to stay competitive.
For institutional investors
If you would like to access our research reports, please reach out to Mark Kong or Michael Pan from the Equity Research team.
Dr Eugene Hong is currently Executive Director of Institutional Banking Group, heading the global healthcare sector within DBS Bank.
He has more than 20 years of experience that spans across the healthcare value chain in senior leadership positions at corporations such as Parkway, GE Healthcare, Novartis and National Australia Bank. His current role at DBS involves developing integrated financial services solutions for the healthcare industry, including the milestone capital market activities in the SGX and IDX. He is also leading a sustainable healthcare ecosystem drive especially with regards to healthcare payments. His current portfolio of clients includes major healthcare players within Asia as well as western multi-national corporates.
He graduated from Monash University in Master Health Service Management & MBBS Medicine and has also obtained a Master of Science, Global Finance from New York University.
Call
Contact us at +65 6682 8865 or +65 6878 2308.
Operating hours: 8.30am to 6.00pm, Mon - Fri (excluding PH)
